Publications by authors named "Dora Illei"
Article Synopsis
- Clinical trial participation for cancer treatment is low, especially among ethnic and racial minority groups, prompting a review to identify successful strategies for increasing enrollment rates.
- The review analyzed 16 studies published between 2012 and 2022 that focused on interventions aimed at overcoming patient and provider barriers and implementing institutional or policy changes.
- Despite identifying themes like patient education and cultural competency, the evidence for effective strategies to increase enrollment remains limited, with few studies providing robust comparative data on accrual rates.
Background: Monovalent booster/additional doses of COVID-19 vaccines were first authorized in August 2021 in the United States. We evaluated the real-world effectiveness of receipt of a monovalent booster/additional dose of COVID-19 vaccine compared with receiving a primary vaccine series without a booster/additional dose.
Methods: Cohorts of individuals receiving a COVID-19 booster/additional dose after receipt of a complete primary vaccine series were identified in 2 administrative insurance claims databases (Optum, CVS Health) supplemented with state immunization information system data between August 2021 and March 2022.